Judge Refuses To Split Upcoming Zetia Antitrust Trial
An upcoming trial on claims accusing Merck and Glenmark of conspiring to delay generic competition for the cholesterol medication Zetia will include only one phase after a Virginia federal judge rejected...To view the full article, register now.
Already a subscriber? Click here to view full article